QS Investors’s Veracyte VCYT Stock Holding History

QS Investors’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,700	Closed	-$251K	–	1259
2020 Q3	$251K	Sell	7,700 -66,200	-90%	-$2.1M	﹤0.01%	993
2020 Q2	$1.92M	Sell	73,900 -6,150	-8%	-$153K	0.03%	513
2020 Q1	$1.95M	Sell	80,050 -32,000	-29%	-$805K	0.03%	421
2019 Q4	$3.08M	Sell	112,050 -1,600	-1%	-$41.4K	0.03%	437
2019 Q3	$2.73M	Hold	113,650	–	–	0.03%	451
2019 Q2	$3.24M	Buy	+113,650	New	+$2.84M	0.04%	409

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

QS Investors's VCYT Position: Q4 2020 in Review

QS Investors sold out of Veracyte (VCYT) in Q4 2020, closing a stake of 7,700 shares — an estimated $251K sold.

QS Investors first reported a position in VCYT in Q2 2019 and held it in 6 quarters. The position peaked at $3.24M in Q2 2019. 222 funds tracked by Wall St. Rank hold VCYT as of Q4 2020.

QS Investors reported no remaining Veracyte position as of Q4 2020 after selling out during the quarter.
QS Investors sold 7,700 Veracyte shares in Q4 2020, an estimated $251K.
QS Investors first reported a position in Veracyte in Q2 2019 and held it in 6 quarters.
QS Investors's Veracyte position peaked at $3.24M in Q2 2019.
222 funds tracked by Wall St. Rank held Veracyte as of Q4 2020.

Based on QS Investors's 13F filing for Q4 2020, filed 10 Feb 2021.